APA 6th Edition

Perše, M. & Cerar, A. (2005). The Effect of Rofecoxib, a Selective COX-2 Inhibitor, on Experimental Colon Tumors. Acta clinica Croatica, 44 (2), 227-228. Retrieved from https://hrcak.srce.hr/15407

---

MLA 8th Edition

Perše, M. and A. Cerar. "The Effect of Rofecoxib, a Selective COX-2 Inhibitor, on Experimental Colon Tumors." Acta clinica Croatica, vol. 44, no. 2, 2005, pp. 227-228. https://hrcak.srce.hr/15407. Accessed 19 Dec. 2024.

---

Chicago 17th Edition

Perše, M. and A. Cerar. "The Effect of Rofecoxib, a Selective COX-2 Inhibitor, on Experimental Colon Tumors." Acta clinica Croatica 44, no. 2 (2005): 227-228. https://hrcak.srce.hr/15407

---

Harvard

Perše, M., and Cerar, A. (2005). 'The Effect of Rofecoxib, a Selective COX-2 Inhibitor, on Experimental Colon Tumors', Acta clinica Croatica, 44(2), pp. 227-228. Available at: https://hrcak.srce.hr/15407 (Accessed 19 December 2024)

---

Vancouver

Perše M, Cerar A. The Effect of Rofecoxib, a Selective COX-2 Inhibitor, on Experimental Colon Tumors. Acta clinica Croatica [Internet]. 2005 [cited 2024 December 19];44(2):227-228. Available from: https://hrcak.srce.hr/15407

---

IEEE

M. Perše and A. Cerar, "The Effect of Rofecoxib, a Selective COX-2 Inhibitor, on Experimental Colon Tumors", Acta clinica Croatica, vol.44, no. 2, pp. 227-228, 2005. [Online]. Available: https://hrcak.srce.hr/15407. [Accessed: 19 December 2024]